Article thumbnail
Location of Repository

Chronic lymphocytic leukemia

By John C. Byrd, Stephan Stilgenbauer and Ian W. Flinn

Abstract

Chronic lymphocytic leukemia (CLL) is one of the most commonly diagnosed leukemias managed by practicing hematologists. For many years patients with CLL have been viewed as similar, with a long natural history and only marginally effective therapies that rarely yielded complete responses. Recently, several important observations related to the biologic significance of VH mutational status and associated ZAP-70 overexpression, disrupted p53 function, and chromosomal aberrations have led to the ability to identify patients at high risk for early disease progression and inferior survival. Concurrent with these investigations, several treatments including the nucleoside analogues, monoclona

Publisher: American Society of Hematology
Year: 2004
OAI identifier: oai:CiteSeerX.psu:10.1.1.980.1384
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://asheducationbook.hemato... (external link)
  • http://asheducationbook.hemato... (external link)
  • http://citeseerx.ist.psu.edu/v... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.